Pediatric inflammatory bowel disease: clinical and molecular genetics.

Pediatric-onset inflammatory bowel disease (IBD) is characterized by distinct phenotypic differences compared to adult-onset IBD. This raises the question whether early (pediatric) onset IBD represents the same disease process occurring in adults but merely at an earlier age or does IBD in children have a very different etiology and pathogenesis but with the same clinical presentation as adults. The use of techniques such as whole genome association studies to perform broad, unbiased screening for the contributions of common genetic variations to complex disease has rapidly assisted in the identification of several novel susceptibility loci associated with pediatric-onset Crohn's disease such as IL23R and ATG16L1. These genes join the already confirmed IBD susceptibility genes such as NOD2/CARD15, IBD5, and DLG5. Therefore, there is hope that advances in the field of clinical and molecular genetics will assist in answering the fundamental question of whether pediatric IBD has a different etiology and pathogenesis compared to adult IBD. This review examines the current status of clinical and molecular genetics of pediatric IBD, and highlights the differences between pediatric and adult IBD in disease phenotypes and genotypes. Finally, the future directions of genetic investigations in pediatric IBD are discussed.

[1]  K. Lunetta.  Genetic Association Studies , 2008, Circulation.

[2]  Iwona Wrobel,et al.  IL‐23 receptor (IL‐23R) gene protects against pediatric Crohn's disease , 2007, Inflammatory bowel diseases.

[3]  Judy H Cho,et al.  Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis , 2007, Nature Genetics.

[4]  Simon Heath,et al.  Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4 , 2007, PLoS genetics.

[5]  H. Drummond,et al.  The contribution of the DLG5 113A variant in early-onset inflammatory bowel disease. , 2007, The Journal of pediatrics.

[6]  U. Broeckel,et al.  DLG5 R30Q Variant Is a Female-Specific Protective Factor in Pediatric Onset Crohn's Disease , 2007, The American Journal of Gastroenterology.

[7]  Thomas Lengauer,et al.  A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 , 2007, Nature Genetics.

[8]  Judy H. Cho,et al.  A Genome-Wide Association Study Identifies IL23R as an Inflammatory Bowel Disease Gene , 2006, Science.

[9]  A. Griffiths,et al.  The natural history of corticosteroid therapy for ulcerative colitis in children. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[10]  M. Vatn,et al.  Ulcerative colitis and clinical course: Results of a 5‐year population‐based follow‐up study (the IBSEN study) , 2006, Inflammatory bowel diseases.

[11]  M. Stoll,et al.  Role of discs large homolog 5. , 2006, World journal of gastroenterology.

[12]  U. Turunen,et al.  Family and twin studies in inflammatory bowel disease. , 2006, World journal of gastroenterology.

[13]  U. Broeckel,et al.  Contribution of OCTN Variants Within the IBD5 Locus to Pediatric Onset Crohn's Disease , 2006, The American Journal of Gastroenterology.

[14]  M. Chamaillard,et al.  Advances and perspectives in the genetics of inflammatory bowel diseases. , 2006, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[15]  M. Daly,et al.  Evidence of transmission ratio distortion of DLG5 R30Q variant in general and implication of an association with Crohn disease in men , 2006, Human Genetics.

[16]  M. Daly,et al.  Association of DLG5 R30Q variant with inflammatory bowel disease , 2005, European Journal of Human Genetics.

[17]  M. Kamm,et al.  Characteristics of intestinal dendritic cells in inflammatory bowel diseases. , 2005, Gastroenterology.

[18]  J. Hugot,et al.  Ileal Involvement Is Age Dependent in Pediatric Crohn's Disease , 2005, Inflammatory bowel diseases.

[19]  T. Giese,et al.  Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease. , 2005, Gastroenterology.

[20]  D. Jewell,et al.  Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. , 2005, Human molecular genetics.

[21]  G. Petersen,et al.  Genomics, genetic epidemiology, and genomic medicine. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[22]  Richard A. Flavell,et al.  Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract , 2005, Science.

[23]  K. Siminovitch,et al.  A risk haplotype in the Solute Carrier Family 22A4/22A5 gene cluster influences phenotypic expression of Crohn's disease. , 2005, Gastroenterology.

[24]  U. Broeckel,et al.  CARD15 gene mutations and risk for early surgery in pediatric-onset Crohn's disease. , 2004, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[25]  M Schwab,et al.  NOD2 (CARD15) mutations in Crohn’s disease are associated with diminished mucosal α-defensin expression , 2004, Gut.

[26]  D. Schwartz,et al.  Toll-like receptors in the pathogenesis of human disease , 2004, Nature Immunology.

[27]  Ruslan Medzhitov,et al.  Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis , 2004, Cell.

[28]  J. Glas,et al.  Crohn's disease is associated with a toll-like receptor-9 polymorphism. , 2004, Gastroenterology.

[29]  T. Mussack,et al.  Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis. , 2004, Clinical immunology.

[30]  K. Van Steen,et al.  Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn’s disease and ulcerative colitis , 2004, Gut.

[31]  Thomas Lengauer,et al.  Genetic variation in DLG5 is associated with inflammatory bowel disease , 2004, Nature Genetics.

[32]  Judy H. Cho,et al.  MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. , 2003, American journal of human genetics.

[33]  C. Tysk.  Genetic susceptibility in Crohn's disease--review of clinical studies. , 2003, The European journal of surgery = Acta chirurgica.

[34]  R. Hoffmann,et al.  Epidemiologic and clinical characteristics of children with newly diagnosed inflammatory bowel disease in Wisconsin: a statewide population-based study. , 2003, The Journal of pediatrics.

[35]  M. Kamm,et al.  The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria , 2003, Gut.

[36]  M. Neurath,et al.  Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.

[37]  S. Kugathasan,et al.  Dermatologic Manifestations of Crohn Disease in Children: Response to Infliximab , 2003, Journal of pediatric gastroenterology and nutrition.

[38]  A. Ekbom,et al.  Sex-specific risks for pediatric onset among patients with Crohn's disease. , 2003, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[39]  M. Daly,et al.  IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis. , 2003, American journal of human genetics.

[40]  M. Weichenthal,et al.  Inducible and Constitutive &bgr;-Defensins Are Differentially Expressed in Crohn's Disease and Ulcerative Colitis , 2003, Inflammatory bowel diseases.

[41]  E. Lindberg,et al.  Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics. , 2003, Gastroenterology.

[42]  L. Cardon,et al.  Analysis of the IBD5 locus and potential gene-gene interactions in Crohn’s disease , 2003, Gut.

[43]  D. Podolsky,et al.  CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. , 2003, Gastroenterology.

[44]  S. Fisher,et al.  Genetic evidence for interaction of the 5q31 cytokine locus and the CARD15 gene in Crohn disease. , 2003, American journal of human genetics.

[45]  M. Olivier.  A haplotype map of the human genome. , 2003, Nature.

[46]  M. Olivier.  A haplotype map of the human genome , 2003, Nature.

[47]  A. Andoh,et al.  Increased expression of interleukin 17 in inflammatory bowel disease , 2003, Gut.

[48]  R. Baldassano,et al.  Inflammatory bowel disease in children 5 years of age and younger , 2002, American Journal of Gastroenterology.

[49]  T. Ahmad,et al.  The molecular classification of the clinical manifestations of Crohn's disease. , 2002, Gastroenterology.

[50]  Judy H. Cho,et al.  Update on the genetics of inflammatory bowel disease , 2001, Current gastroenterology reports.

[51]  Sinead B. O'Leary,et al.  Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease , 2001, Nature Genetics.

[52]  A. Andriulli,et al.  Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study , 2001, American Journal of Gastroenterology.

[53]  A. Andriulli,et al.  Familial expression of anti- Saccharomyces cerevisiae mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study , 2001 .

[54]  Mourad Sahbatou,et al.  Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease , 2001, Nature.

[55]  R. Lynn,et al.  Prospective survey of childhood inflammatory bowel disease in the British Isles , 2001, The Lancet.

[56]  K. Abrams,et al.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis , 2001, Gut.

[57]  D. Podolsky,et al.  Differential Alteration in Intestinal Epithelial Cell Expression of Toll-Like Receptor 3 (TLR3) and TLR4 in Inflammatory Bowel Disease , 2000, Infection and Immunity.

[58]  S. Vermeire,et al.  Familial and Sporadic Inflammatory Bowel Disease: Different Entities? , 2000, Inflammatory bowel diseases.

[59]  H. Steinhart.  Maintenance therapy in Crohn's disease. , 2000, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[60]  E S Lander,et al.  Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. , 2000, American journal of human genetics.

[61]  A. Macpherson,et al.  Why children with inflammatory bowel disease are diagnosed at a younger age than their affected parent , 1999, Gut.

[62]  A Wajda,et al.  Epidemiology of Crohn's disease and ulcerative colitis in a central Canadian province: a population-based study. , 1999, American journal of epidemiology.

[63]  J. C. Jones,et al.  References Subscriptions Permissions Email Alerts A Novel Model of Inflammatory Bowel Disease: Mice Deficient for the Multiple Drug Resistance Gene, mdr1a, Spontaneously Develop Colitis , 2013 .

[64]  D. Franchimont,et al.  Anticipation in familial Crohn’s disease , 1998, Gut.

[65]  N. Breslin,et al.  Monozygotic twins with Crohn’s disease and ulcerative colitis: a unique case report , 1997, Gut.

[66]  B. Childs,et al.  Crohn's disease: influence of age at diagnosis on site and clinical type of disease. , 1996, Gastroenterology.

[67]  P. Rutgeerts,et al.  Familial aggregation in Crohn's disease: increased age-adjusted risk and concordance in clinical characteristics. , 1996, Gastroenterology.

[68]  J. Belaiche,et al.  Clinical characteristics of Crohn's disease in 72 families. , 1996, Gastroenterology.

[69]  R. Pounder,et al.  Genetics versus environment in inflammatory bowel disease: results of a British twin study , 1996, BMJ.

[70]  S. Targan,et al.  Familial empirical risks for inflammatory bowel disease: differences between Jews and non-Jews. , 1993, Gut.

[71]  T. Sørensen,et al.  Familial occurrence of inflammatory bowel disease. , 1991, The New England journal of medicine.

[72]  E. Lindberg,et al.  Ulcerative colitis and Crohn's disease in an unselected population of monozygotic and dizygotic twins. A study of heritability and the influence of smoking. , 1988, Gut.

[73]  J. Spencer,et al.  FAMILY OCCURRENCES OF ULCERATIVE COLITIS, REGIONAL ENTERITIS, AND ILEOCOLITIS. , 1963, Annals of internal medicine.

[74]  R. Baldassano,et al.  Children with early-onset inflammatory bowel disease (IBD): analysis of a pediatric IBD consortium registry. , 2005, The Journal of pediatrics.

[75]  S. Targan,et al.  Mutations in NOD2 are associated with fibrostenosing disease in patients with Crohn's disease. , 2002, Gastroenterology.

[76]  T. Sørensen,et al.  Concordance of inflammatory bowel disease among Danish twins. Results of a nationwide study. , 2000, Scandinavian journal of gastroenterology.

[77]  T. Bayless.  Maintenance therapy for Crohn's disease. , 1996, Gastroenterology.